NO173972C - Fremgangsmaate ved fremstilling av et syrebindende brusende preparat - Google Patents

Fremgangsmaate ved fremstilling av et syrebindende brusende preparat

Info

Publication number
NO173972C
NO173972C NO870243A NO870243A NO173972C NO 173972 C NO173972 C NO 173972C NO 870243 A NO870243 A NO 870243A NO 870243 A NO870243 A NO 870243A NO 173972 C NO173972 C NO 173972C
Authority
NO
Norway
Prior art keywords
alcalin
preparation
couples
mono
acide
Prior art date
Application number
NO870243A
Other languages
English (en)
Norwegian (no)
Other versions
NO870243L (no
NO870243D0 (no
NO173972B (no
Inventor
Rene Tarral
Jacky Mention
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of NO870243D0 publication Critical patent/NO870243D0/no
Publication of NO870243L publication Critical patent/NO870243L/no
Publication of NO173972B publication Critical patent/NO173972B/no
Publication of NO173972C publication Critical patent/NO173972C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Processing Of Solid Wastes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
NO870243A 1986-01-22 1987-01-20 Fremgangsmaate ved fremstilling av et syrebindende brusende preparat NO173972C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8600839A FR2593065B1 (fr) 1986-01-22 1986-01-22 Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.

Publications (4)

Publication Number Publication Date
NO870243D0 NO870243D0 (no) 1987-01-20
NO870243L NO870243L (no) 1987-07-23
NO173972B NO173972B (no) 1993-11-22
NO173972C true NO173972C (no) 1994-03-02

Family

ID=9331358

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870243A NO173972C (no) 1986-01-22 1987-01-20 Fremgangsmaate ved fremstilling av et syrebindende brusende preparat

Country Status (32)

Country Link
US (1) US4824664A (cs)
EP (1) EP0233853B1 (cs)
JP (2) JPH0669964B2 (cs)
KR (1) KR950002883B1 (cs)
CN (1) CN1032841C (cs)
AT (1) ATE56356T1 (cs)
AU (1) AU599071B2 (cs)
BG (1) BG50924A3 (cs)
CA (1) CA1299583C (cs)
CS (1) CS265231B2 (cs)
DD (1) DD285720A5 (cs)
DE (1) DE3764816D1 (cs)
DK (1) DK30087A (cs)
EG (1) EG18194A (cs)
ES (1) ES2017531B3 (cs)
FI (1) FI90941C (cs)
FR (1) FR2593065B1 (cs)
GR (1) GR3001150T3 (cs)
HU (1) HU196305B (cs)
IE (1) IE59652B1 (cs)
IL (1) IL81313A (cs)
MX (1) MX9203546A (cs)
NO (1) NO173972C (cs)
NZ (1) NZ218895A (cs)
OA (1) OA08464A (cs)
PH (1) PH25292A (cs)
PL (1) PL154164B1 (cs)
PT (1) PT84148B (cs)
SU (1) SU1605913A3 (cs)
TN (1) TNSN87005A1 (cs)
ZA (1) ZA87433B (cs)
ZW (1) ZW587A1 (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
YU120988A (en) * 1988-06-23 1990-06-30 Lek Tovarna Farmacevtskih Process for preparing new dispersion pills of cimetidine
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
GB2222772B (en) * 1988-09-20 1992-05-13 Glaxo Group Ltd Pharmaceutical compositions
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
FR2648710B1 (fr) * 1989-06-23 1994-01-14 Glaxo Sa Laboratoires Composition pharmaceutique a base de ranitidine et son procede de preparation
DE4027927A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Brausekomponente und verfahren zu ihrer herstellung
AU639137B2 (en) * 1990-09-21 1993-07-15 Merrell Dow Pharmaceuticals Inc. Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition
GB9027827D0 (en) * 1990-12-21 1991-02-13 Glaxo Laboratoires Pharmaceutical compositions
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5468504A (en) * 1990-12-21 1995-11-21 Laboratoires Glaxo S.A. Effervescent pharmaceutical compositions
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
DK0525388T3 (da) * 1991-07-01 1996-02-05 Gergely Gerhard Pastil eller tyggetablet
CA2112663C (en) * 1991-07-01 2002-04-23 Thomas Gergely Effervescent systems using reaction doping agents
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
FR2685199A1 (fr) * 1991-12-24 1993-06-25 Stirnweiss Charles Procede de fabrication d'un granule effervescent et dispositif pour la mise en óoeuvre de ce procede.
EP0574624B1 (en) * 1992-06-17 1997-09-10 Laboratoires Glaxo Sa Pharmaceutical compositions
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
US6274172B1 (en) 1995-07-05 2001-08-14 Smithkline Beecham Laboratoires Pharmaceutiques Therapeutic effervescent compositions
FR2736264B1 (fr) * 1995-07-05 1997-09-26 Smithkline Beecham Lab Couples effervescents, formulations pharmaceutiques les contenant, et leur utilisation en therapeutique
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
US5989588A (en) * 1996-10-04 1999-11-23 Merck & Co., Inc. Methods and compositions for preventing and treating heartburn
US5728401A (en) * 1997-04-16 1998-03-17 Ranbaxy Laboratories, Ltd. Effervescent ranitidine formulations
US6165506A (en) * 1998-09-04 2000-12-26 Elan Pharma International Ltd. Solid dose form of nanoparticulate naproxen
RU2160601C1 (ru) * 1999-11-18 2000-12-20 Закрытое акционерное общество "Межрегиональный центр "Адаптоген" Растворимая шипучая лекарственная композиция с растительным экстрактом
US6264984B1 (en) 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
US6554139B1 (en) * 2000-06-01 2003-04-29 Parker-Hannifin Corporation Extension and locking assembly for dripless element, and container therefore
US6426111B1 (en) 2000-06-02 2002-07-30 Gerald Phillip Hirsch Effervescent mixtures and methods of making
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
US7776831B2 (en) 2006-02-01 2010-08-17 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
KR102193599B1 (ko) 2014-09-17 2020-12-21 스티어라이프 인디아 프라이빗 리미티드 발포성 조성물 및 이의 제조방법
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
US10357668B2 (en) 2016-03-31 2019-07-23 L'oreal Inhibiting color fading with layer-by-layer films
US10383810B2 (en) 2016-03-31 2019-08-20 L'oreal Inhibiting color fading with layer-by-layer films

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1764996A (en) * 1928-04-12 1930-06-17 Squibb & Sons Inc Stable effervescent composition
US2147743A (en) * 1938-08-05 1939-02-21 Baker Chem Co J T Pharmaceutical preparation
ES315494A1 (es) * 1965-07-05 1966-02-01 Serra Jorge Miquel Un procedimiento para la preparaciën de un componente acido para composiciones efervescentes
FR1484202A (fr) * 1965-07-05 1967-06-09 Andreu Sa Dr Procédé de préparation d'un composé acide pour compositions effervescentes
AT307616B (de) * 1969-05-02 1973-05-25 Biochemie Gmbh Verfahren zur Herstellung einer Brausezubereitung
US3887700A (en) * 1969-11-28 1975-06-03 Aspro Nicholas Ltd Analgesic formulations
FR2092893B1 (cs) * 1970-06-29 1973-07-13 Bru Jean
FR2132521A1 (en) * 1971-04-06 1972-11-24 Sofrader Sa Effervescent tablets prdn - by controlled drying in effervescent granule formation
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
US4289751A (en) * 1979-06-29 1981-09-15 Merck & Co., Inc. Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
US4522943A (en) * 1981-05-18 1985-06-11 Bristol-Myers Company Chemical compounds
US4503051A (en) * 1981-05-18 1985-03-05 Bristol-Myers Company Substituted 3-cyclobutene-1,2-diones, pharmaceutical compositions thereof and methods of use
HU185457B (en) * 1981-09-25 1985-02-28 Richter Gedeon Vegyeszet Process for preparating cimetidine-z

Also Published As

Publication number Publication date
KR950002883B1 (ko) 1995-03-28
JPH0669964B2 (ja) 1994-09-07
GR3001150T3 (en) 1992-06-25
CS35587A2 (en) 1988-12-15
FI90941B (fi) 1994-01-14
PL263720A1 (en) 1988-07-21
PT84148A (en) 1987-02-01
CN87100378A (zh) 1987-08-19
NO870243L (no) 1987-07-23
BG50924A3 (bg) 1992-12-15
ES2017531B3 (es) 1991-02-16
NZ218895A (en) 1989-09-27
CS265231B2 (en) 1989-10-13
PL154164B1 (en) 1991-07-31
HU196305B (en) 1988-11-28
DD285720A5 (de) 1991-01-03
PH25292A (en) 1991-04-30
AU6789987A (en) 1987-07-23
FR2593065A1 (fr) 1987-07-24
NO870243D0 (no) 1987-01-20
ATE56356T1 (de) 1990-09-15
IE59652B1 (en) 1994-03-09
HUT43950A (en) 1988-01-28
IL81313A (en) 1992-02-16
DK30087D0 (da) 1987-01-20
AU599071B2 (en) 1990-07-12
NO173972B (no) 1993-11-22
SU1605913A3 (ru) 1990-11-07
FI870199L (fi) 1987-07-23
OA08464A (fr) 1988-07-29
FI870199A0 (fi) 1987-01-19
JPS62215536A (ja) 1987-09-22
TNSN87005A1 (fr) 1990-01-01
DE3764816D1 (de) 1990-10-18
MX9203546A (es) 1992-08-01
EG18194A (fr) 1994-11-30
ZA87433B (en) 1987-08-26
DK30087A (da) 1987-07-23
FR2593065B1 (fr) 1988-09-09
FI90941C (fi) 1994-04-25
EP0233853B1 (fr) 1990-09-12
US4824664A (en) 1989-04-25
ZW587A1 (en) 1987-06-17
CA1299583C (en) 1992-04-28
IE870120L (en) 1987-07-22
PT84148B (pt) 1989-03-30
KR880001286A (ko) 1988-04-22
JPH08175976A (ja) 1996-07-09
CN1032841C (zh) 1996-09-25
EP0233853A1 (fr) 1987-08-26

Similar Documents

Publication Publication Date Title
NO173972C (no) Fremgangsmaate ved fremstilling av et syrebindende brusende preparat
PT78179A (fr) Procede de preparation de nouveaux sulfates avec activite anti--thrombotique et hypolipemiante et de compositions pharmaceuti-ques les contenant
EP0658348A3 (en) Benzothiophene derivative inclusion complexes with aqueous solutions containing cyclodextrins.
DZ1758A1 (fr) Procédé pour la préparation d'aryl-piperidine carbinols.
DZ2641A1 (fr) Nouveaux procédés pour la préparation d'oméprazole.
EP1092717A3 (fr) Nouveaux dérivés polycycliques azaindolinques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
DE3172458D1 (en) Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound
AU2301288A (en) Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections
OA08630A (fr) Fraction immunogène active à l'égard des bilharzioses, sa préparation, compositions immunisantes la contenant.
FR2703880B1 (fr) Utilisation de dérivés de l'acide 7-éthynyl alpha-(méthoxy-méthylène) 1-naphtalène acétique pour la préparation de compositions fongicides.
ES507350A0 (es) Procedimiento de preparacion de nuevos derivados biciclo (2.2.1)heptanos.
TR23271A (tr) En asagi % 95.5 safliginda p-ksilol'un kazanilmasina mahsus usul
FR2434158A1 (fr) Nouveaux derives de 1,3-benzoxazine-2,4-dione, leur preparation et leur application en tant que medicaments
OA06879A (fr) Procédé de préparation de dérivés d'hétéroprostaglandines.
FR2695123B1 (fr) Procédé pour la préparation de composés éthaniques fluorés.
IT1282289B1 (it) 17-idrossiimminoalchil e 17-idrossiimminometilalchenil ciclopentaperidrofenantreni attivi sul sistema cardiovascolare,
AU545065B2 (en) Pharmaceutical formulations containing prostaglandin
UA28705A (uk) Композиція інгредієнтів до настойки солодкої "княжна"
FR2694548B1 (fr) Procédé de préparation de nitrure d'aluminium.
DK0571710T3 (da) Skobund
OA09208A (fr) "Procédé de préparation de dérivés de la thiéno-triazolo-diazépine".